MLYS
Mineralys Therapeutics, Inc.
26.90$
-8.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.7% | 100.0% | 98.6% | 99.0% | 99.7% | 99.9% | |
| 94.8% | 95.4% | 76.6% | 19.6% | 55.4% | 26.1% | |
| 94.8% | 95.4% | 96.2% | 94.0% | 96.3% | 99.2% | |
| 342.1% | 306.1% | 145.7% | 4.2% | 7.1% | 2.3% | |
| 342.1% | 45.4% | 7.0% | 4.2% | 7.1% | 2.3% | |
| 302.8% | – | – | – | – | – | |
| 35.6% | 6.9% | 1.7% | 0.2% | 0.2% | 0.3% | |
| -242.1% | -206.1% | -45.7% | 95.8% | 92.9% | 97.7% | |
| -242.5% | -206.8% | -46.1% | -49.6% | -146.9% | -69.1% | |
| 311.6% | 44.8% | 4.5% | 14.4% | 23.6% | 10.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.